latanoprost/timolol sandoz 50/5 latanoprost 50 microgram/ml timolol 5 mg/ml eye drops
sandoz pty ltd - latanoprost,timolol maleate -
latanoprost/timolol an 50/5 latanoprost 50 microgram/ml + timolol (as maleate) 5 mg/ml eye drop solution bottle
juno pharmaceuticals pty ltd - latanoprost,timolol maleate -
apo-latanoprost/timolol 0.05/5 eye drops latanoprost 50 ug/ml and timolol (as maleate) 5 mg/ml bottle
arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; sodium hydroxide; dibasic sodium phosphate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.
lantim 50/5 latanoprost 50 microgram/ml and timolol 5 mg/ml (as maleate) eye drops solution bottle
juno pharmaceuticals pty ltd - latanoprost,timolol maleate -
latanoprost/timolol eg 50 µg/ml - 5 mg/ml eye drops sol.
eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 0,05 mg/ml - eye drops, solution - 50 µg/ml - 5 mg/ml - latanoprost 0.05 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations
latanoprost-timolol ab 50 µg/ml - 5 mg/ml eye drops sol. dropper cont.
aurobindo sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 0,05 mg/ml - eye drops, solution - 0,005 % - 0,5 % - timolol maleate 6.83 mg/ml; latanoprost 0.05 mg/ml - timolol, combinations
xalamol 50/5 latanoprost 50 microgram/ml + timolol (as maleate) 5 mg/ml eye drops bottle
viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.
latanocom latanoprost 50 microgram/ml, timolol (as maleate) 5 mg/ml eye drops
aspen pharmacare australia pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate; water for injections; sodium chloride; hydrochloric acid; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanocom should not be used to initiate therapy.
apo-latanoprost/timolol 0.05/5 eye drops latanoprost 50 ug/ml and timolol (as maleate) 5 mg/ml bottle
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.
latanoprost/timolol zentiva 50mcg/ml + 5 mg/ml eye drops solution
sanofi-aventis ireland limited t/a sanofi - latanoprost, timolol maleate - eye drops solution - 50mcg/ml + 5 mg/ml - beta blocking agents